Andrew Sutton is a Director of Business Development who has over the last 5 years worked with large, midsize and emerging biotech and pharma companies, as well as research sites.

Andrew believes strongly in the value of technology to provide a better trial experience for Sites, Patients and Sponsors. Andrew has spent the last five years working with technology solutions designed to automate and reduce administrative burdens for Sites and Patients while participating in a clinical trial, as well as provide Sponsors with more visibility and transparency into the study to better design a site-centric and patient-friendly trial.

Andrew holds a Master’s in Business Administration from Leon Hess Business School, Monmouth University.